Gentamicin supplemented polyvinylidenfluoride mesh materials enhance tissue integration due to a transcriptionally reduced MMP-2 protein expression

Abstract

BackgroundA beneficial effect of gentamicin supplemented mesh material on tissue integration is known. To further elucidate the interaction of collagen and MMP-2 in chronic foreign body reaction and to determine the significance of the MMP-2-specific regulatory element (RE-1) that is known to mediate 80% of the MMP-2 promoter activity, the spatial and temporal transcriptional regulation of the MMP-2 gene was analyzed at the cellular level.MethodsA PVDF mesh material was surface modified by plasma-induced graft polymerization of acrylic acid (PVDF+PAAc). Three different gentamicin concentrations were bound to the provided active sites of the grafted mesh surfaces (2, 5 and 8 μg/mg). 75 male transgenic MMP-2/LacZ mice harbouring the LacZ reporter gene under control of MMP-2 regulatory sequence -1241/+423, excluding the RE-1 were randomized to five groups. Bilateral of the abdominal midline one of the five different meshes was implanted subcutaneously in each animal. MMP-2 gene transcription (anti-ß-galactosidase staining) and MMP-2 protein expression (anti-MMP-2 staining) were analyzed semiquantitatively by immunohistochemistry 7, 21 and 90 days after mesh implantation. The collagen type I/III ratio was analyzed by cross polarization microscopy to determine the quality of mesh integration.ResultsThe perifilamentary ß-galactosidase expression as well as the collagen type I/III ratio increased up to the 90th day for all mesh modifications, whereas no significant changes could be observed for MMP-2 protein expression between days 21 and 90. Both the 5 and 8 μg/mg gentamicin group showed significantly reduced levels of ß-galactosidase expression and MMP-2 positive stained cells when compared to the PVDF group on day 7, 21 and 90 respectively (5 μg/mg: p < 0.05 each; 8 μg/mg: p < 0.05 each). Though the type I/III collagen ratio increased over time for all mesh modifications significant differences to the PVDF mesh were only detected for the 8 μg/mg group at all 3 time points (p < 0.05 each).ConclusionsOur current data indicate that lack of RE-1 is correlated with increased mesh induced MMP-2-gene expression for coated as well as for non-coated mesh materials. Gentamicin coating reduced MMP-2 transcription and protein expression. For the 8 μg/mg group this effect is associated with an increased type I/III collagen ratio. These findings suggest that gentamicin is beneficial for tissue integration after mesh implantation, which possibly is mediated via RE-1.

The impact of an online Facebook support group for people with multiple sclerosis on non-active users

“…2012). MS is a relatively common disease, with a global prevalence rate that is on the rise (Young 2011).…”

Gentamicin for prevention of intraoperative mesh contamination: demonstration of high bactericide effect (in vitro) and low systemic bioavailability (in vivo)

“…Gentamicin has also been shown to promote wound healing [26,27]. In an experimental study in transgenic MMP-2/LacZ mice, gentamicin coating of polyvinylidenfluoride meshes reduced the MMP-2 transcription and protein expression, even associated with an increase in tape I/III collagen ratio, suggesting that gentamicin is beneficial for tissue integration after mesh implantation [27]. The maximal count of 10 4 CFU used in the present study is significantly higher than intraoperative counts generally encountered in surgical routine.…”

“…Gentamicin has a broad spectrum of effects against Gram-negative pathogens and S. aureus and S. epidermidis. Gentamicin has also been shown to promote wound healing [26,27]. In an experimental study in transgenic MMP-2/LacZ mice, gentamicin coating of polyvinylidenfluoride meshes reduced the MMP-2 transcription and protein expression, even associated with an increase in tape I/III collagen ratio, suggesting that gentamicin is beneficial for tissue integration after mesh implantation [27].…”

Methodology of fibroblast and mesenchymal stem cell coating of surgical meshes: A pilot analysis

“…Multiple strategies are being tested for optimization of mesh–surface properties to reduce deletirious tissue–mesh reactions . Researchers have attempted to grow certain cells on medical scaffolds to improve biocompatibility and graft function .…”